Black Diamond Therapeutics, Inc. (BDTX)
NASDAQ: BDTX · Real-Time Price · USD
2.180
+0.030 (1.40%)
At close: Mar 9, 2026, 4:00 PM EDT
2.200
+0.020 (0.92%)
After-hours: Mar 9, 2026, 7:17 PM EDT
BDTX Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 124 | 121 | 145 | 65 | 193 | 1,154 | |
| Market Cap Growth | -3.73% | -16.54% | 121.66% | -66.10% | -83.26% | - | |
| Enterprise Value | 8 | 31 | 27 | -50 | -13 | 829 | |
| Last Close Price | 2.18 | 2.14 | 2.81 | 1.80 | 5.33 | 32.05 | |
| PB Ratio | 0.98 | 1.45 | 1.24 | 0.57 | 0.99 | 3.75 | |
| P/TBV Ratio | 0.98 | 1.45 | 1.24 | 0.57 | 0.99 | 3.75 | |
| Debt / Equity Ratio | 0.16 | 0.27 | 0.22 | 0.24 | 0.14 | 0.03 | |
| Net Debt / Equity Ratio | -0.92 | -0.92 | -0.91 | -0.82 | -0.93 | -0.99 | |
| Net Debt / EBITDA Ratio | -7.65 | 1.01 | 1.23 | 1.02 | 1.43 | 4.41 | |
| Net Debt / FCF Ratio | -5.43 | 1.23 | 1.59 | 1.11 | 1.76 | 5.86 | |
| Quick Ratio | 8.72 | 4.79 | 6.69 | 8.05 | 8.87 | 22.16 | |
| Current Ratio | 8.94 | 4.92 | 6.82 | 8.37 | 9.12 | 22.48 | |
| Return on Equity (ROE) | 19.23% | -69.67% | -70.94% | -58.52% | -49.87% | -29.17% | |
| Return on Assets (ROA) | 6.26% | -33.71% | -34.33% | -28.73% | -27.47% | -17.82% | |
| Return on Capital Employed (ROCE) | 10.40% | -74.30% | -62.20% | -65.80% | -56.60% | -22.10% | |
| Earnings Yield | 17.31% | -57.54% | -56.82% | -139.28% | -65.04% | -5.83% | |
| FCF Yield | 17.19% | -51.45% | -46.00% | -130.27% | -53.27% | -4.53% | |
| Buyback Yield / Dilution | -6.44% | -25.19% | -21.00% | -0.38% | -9.97% | -1485.31% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.